Compounds > plumbagin
Page last updated: 2024-08-21

plumbagin and Adenocarcinoma

plumbagin has been researched along with Adenocarcinoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Baranoski, A; Biazi, BI; Coatti, GC; Corveloni, AC; Lepri, SR; Mancilla, IA; Mantovani, MS; Marques, LA; Zanetti, TA1
Biswal, BK; Panda, M; Pandey, K; Tripathi, SK1
Fischer, JW; Hafeez, BB; Meske, L; Mustafa, A; Sheikhani, MO; Singh, A; Verma, AK; Zhong, W1
Fischer, JW; Hafeez, BB; Mustafa, A; Verma, AK; Witkowsky, O; Zhong, W1
Priya, S; Rakesh, S; Ratheeshkumar, T; Rojini, G; Srinivas, G; Thasni, KA1

Other Studies

5 other study(ies) available for plumbagin and Adenocarcinoma

ArticleYear
Molecular pathways related to the control of proliferation and cell death in 786-O cells treated with plumbagin.
    Molecular biology reports, 2019, Volume: 46, Issue:6

    Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Autophagy; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Kidney Neoplasms; Naphthoquinones; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phytochemicals; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases

2019
Prooxidative activity of plumbagin induces apoptosis in human pancreatic ductal adenocarcinoma cells via intrinsic apoptotic pathway.
    Toxicology in vitro : an international journal published in association with BIBRA, 2020, Volume: 65

    Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; DNA Damage; Humans; Membrane Potential, Mitochondrial; Mitochondria; Naphthoquinones; Oxidative Stress; Pancreatic Neoplasms; Reactive Oxygen Species; Signal Transduction

2020
Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCĪµ, Stat3, and Epithelial-to-Mesenchymal Transition Markers.
    Cancer prevention research (Philadelphia, Pa.), 2015, Volume: 8, Issue:5

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Biomarkers; Carcinogenesis; Epithelial-Mesenchymal Transition; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Naphthoquinones; Orchiectomy; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Protein Kinase C-epsilon; PTEN Phosphohydrolase; Signal Transduction; STAT3 Transcription Factor

2015
Plumbagin inhibits prostate cancer development in TRAMP mice via targeting PKCĪµ, Stat3 and neuroendocrine markers.
    Carcinogenesis, 2012, Volume: 33, Issue:12

    Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Antigens, Polyomavirus Transforming; Chromogranin A; Disease Models, Animal; Male; Mice; Mice, Transgenic; Naphthoquinones; Phosphorylation; Proliferating Cell Nuclear Antigen; Prostatic Neoplasms; Protein Kinase C-epsilon; STAT3 Transcription Factor; Synaptophysin

2012
Estrogen-dependent cell signaling and apoptosis in BRCA1-blocked BG1 ovarian cancer cells in response to plumbagin and other chemotherapeutic agents.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:4

    Topics: Actins; Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Line, Tumor; Cisplatin; Doxorubicin; Estrogen Receptor alpha; Female; Genes, BRCA1; Humans; Lethal Dose 50; Naphthoquinones; Ovarian Neoplasms; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Small Interfering; Signal Transduction; Tamoxifen; Transfection; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases

2008